BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $222,000 | -34.9% | 2,859 | -28.0% | 0.02% | -33.3% |
| Q4 2021 | $341,000 | +6.9% | 3,973 | +0.3% | 0.03% | -3.2% |
| Q3 2021 | $319,000 | +0.3% | 3,962 | +0.3% | 0.03% | -3.1% |
| Q2 2021 | $318,000 | -0.6% | 3,950 | -0.8% | 0.03% | -11.1% |
| Q4 2020 | $320,000 | +13.9% | 3,982 | +18.3% | 0.04% | -29.4% |
| Q4 2019 | $281,000 | -3.4% | 3,365 | +1.0% | 0.05% | -10.5% |
| Q3 2019 | $291,000 | +7.0% | 3,331 | +0.3% | 0.06% | +7.5% |
| Q2 2019 | $272,000 | -2.2% | 3,322 | -2.7% | 0.05% | -7.0% |
| Q1 2019 | $278,000 | +27.5% | 3,414 | +3.3% | 0.06% | +18.8% |
| Q4 2018 | $218,000 | +707.4% | 3,305 | +297.2% | 0.05% | +585.7% |
| Q3 2015 | $27,000 | -99.1% | 832 | -98.0% | 0.01% | -99.1% |
| Q2 2015 | $2,974,000 | +11.2% | 42,542 | +8.9% | 0.80% | +21.6% |
| Q1 2015 | $2,675,000 | +4.0% | 39,048 | +11.3% | 0.66% | -4.1% |
| Q4 2014 | $2,571,000 | +2.3% | 35,078 | +0.2% | 0.69% | -9.2% |
| Q3 2014 | $2,513,000 | +4.5% | 35,011 | +5.3% | 0.76% | -11.4% |
| Q2 2014 | $2,405,000 | +1251.1% | 33,261 | +1277.8% | 0.86% | +1042.7% |
| Q1 2014 | $178,000 | +53.4% | 2,414 | +45.3% | 0.08% | +13.6% |
| Q4 2013 | $116,000 | +5700.0% | 1,661 | +4933.3% | 0.07% | +6500.0% |
| Q2 2013 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |